CLINIMAPS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 10 Dec 2021)
What this means for you
Registered since 19 Jul 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86731484
- Registration number
- 5004983
- Mark type
- Stylized text
- Filed
- 20 Aug 2015
- Published for opposition
- 12 Jan 2016
- Registered
- 19 Jul 2016
- Attorney of record
- James Klobucar
Goods and services
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical device, medical diagnostic, pharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials and applications for government approval; Business consulting and management in the field of product development for the pharmaceutical, biotechnology, medical diagnostic, and medical device industries
Owner
- FOCUS MEDICAL COMMUNICATIONS LLC, PARSIPPANY, NJ, US
- Ampligent, LLC, Parsippany, NJ, US
- Ampligent, LLC, Parsippany, NJ, US
- Ampligent, LLC, Parsippany, NJ, US
Prosecution history
- 20 Jul 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 10 Dec 2021 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 10 Dec 2021 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 Dec 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Sept 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 08 Sept 2021 — TEAS SECTION 8 & 15 RECEIVED
- 19 Jul 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Jul 2016 — REGISTERED-PRINCIPAL REGISTER
- 14 Jun 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 12 Jun 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 May 2016 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Apr 2016 — USE AMENDMENT FILED
- 21 May 2016 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Apr 2016 — TEAS STATEMENT OF USE RECEIVED
- 26 Apr 2016 — TEAS CHANGE OF CORRESPONDENCE RECEIVED